M&A Healthcare Advisors Brokers Innovo Detox Sale to R&S Holdings
MAHA advised Pennsylvania-based substance use disorder treatment provider Innovo Detox on its acquisition by R&S Holdings, Inc.
M&A Healthcare Advisors (MAHA), a FINRA-licensed investment bank specializing in the healthcare sector, announced it served as the exclusive financial advisor for Innovo Detox in a completed sale transaction to R&S Holdings, Inc.
Innovo Detox, headquartered in Pennsylvania, provides substance use disorder treatment and drug and alcohol recovery services. The facility is among a growing number of behavioral health operators attracting private capital as demand for SUD treatment services continues to expand across the United States.
Read more Small Business Payroll Setup: Key Steps to Avoid Tax Errors →
MAHA has positioned itself as a niche advisor in healthcare mergers and acquisitions, focusing on deals within behavioral health, addiction treatment, and related subsectors. The firm's FINRA licensing distinguishes it from unregistered M&A consultants operating in the same space, offering clients a regulated transaction process.
The behavioral health and addiction treatment sector has drawn sustained investor interest in recent years, driven by rising rates of substance use disorders, expanded insurance parity requirements, and a broader push to integrate mental health services into mainstream healthcare delivery. Transactions involving detox and residential treatment providers have become increasingly common as consolidation accelerates.
Financial terms of the Innovo Detox transaction were not disclosed. Continue reading at All Financial Services & Investing.
